Evidence map›Paper›PMID 41596591›Full record

ArticleInternational journal of molecular sciences2026

Therapeutic Potential of a Novel

Qingqing Yang, Baoyu Gan, Zhonglin Wang, Shan Jiang, Cao Qiu, Yawen Wang, Bing Liu, Xiaoyan Zeng

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qingqing YangDepartment of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.ORCID 0000-0001-6046-5465
Baoyu GanBioBank, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Zhonglin WangDepartment of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Shan JiangDepartment of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Cao QiuState Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, Jilin University, Changchun 130062, China.
Yawen WangBioBank, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Bing LiuBioBank, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.ORCID 0000-0003-1670-6115
Xiaoyan ZengDepartment of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.ORCID 0000-0002-1107-7965

Funding

National Key Research and Development Program of China 2025YFC3408500National Natural Science Foundation of China 32270151
6 · The paper itself

Abstract

A novel lytic bacteriophage, XAN_XB1, was isolated from hospital wastewater through host bacterial enrichment and evaluated for its potential in controlling multidrug-resistant

Indexed as

BacteriophagesGenome, ViralGram-Negative Bacterial InfectionsPhage TherapyStenotrophomonas maltophiliaAnimalsDisease Models, AnimalMicePhylogenyWhole Genome Sequencingbacteriophagedrug-resistant bacteriaphage therapyStenotrophomonas maltophilia

Identifiers

PMID41596591
PMCPMC12841729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.